SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009247
Filing Date
2024-03-07
Accepted
2024-03-07 17:13:22
Documents
20
Period of Report
2024-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57619
2 ex10-1.htm EX-10.1 1133700
3 ex10-2.htm EX-10.2 1222527
4 ex99-1.htm EX-99.1 12560
5 ex99-1_001.jpg GRAPHIC 3119
6 ex10-1_001.jpg GRAPHIC 8552
7 ex10-2_001.jpg GRAPHIC 8116
  Complete submission text file 0001493152-24-009247.txt   3062190

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE xtnt-20240307.xsd EX-101.SCH 3027
9 XBRL LABEL FILE xtnt-20240307_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE xtnt-20240307_pre.xml EX-101.PRE 22367
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3554
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 24731234
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)